Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Janjan

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Survey on use of palliative radiotherapy in hospice careStephen Lutz, Carol Spence, Edward Chow, et al.
Journal of Medical Economics|February 14, 2022
Clinical and economic burden of HPV-related cancers in the US veteran populationKunal Saxena, Rachel Souza Dawson, Anissa Cyhaniuk, et al.
Journal of Managed Care & Specialty Pharmacy|September 4, 2020
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective AnalysisQing Huang, Sujana Borra, Jieni Li, et al.
Pain|September 1, 1991
Epidural opiates and local anesthetics for the management of cancer painQuinn Hogan, David J Haddox, Stephen Abram, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2006
Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14Andre Konski, Michelle Desilvio, William Hartsell, et al.
Future Oncology (London, England)|August 30, 2023
Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?Stephen J Freedland, Krishnan Ramaswamy, Ahong Huang, et al.
Frontiers in Medicine|July 24, 2023
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigationsPatrick Silva, Nora Janjan, Kenneth S Ramos, et al.
Future Oncology (London, England)|October 13, 2022
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?Daniel J George, Krishnan Ramaswamy, Ahong Huang, et al.
American Journal of Clinical Oncology|June 24, 2009
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastasesAndre Konski, Jennifer James, William Hartsell, et al.
Cancer|February 25, 2003
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic indexArthur Hung, Christopher Crane, Marc Delclos, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Survey on use of palliative radiotherapy in hospice careStephen Lutz, Carol Spence, Edward Chow, et al.
Journal of Medical Economics|February 14, 2022
Clinical and economic burden of HPV-related cancers in the US veteran populationKunal Saxena, Rachel Souza Dawson, Anissa Cyhaniuk, et al.
Journal of Managed Care & Specialty Pharmacy|September 4, 2020
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective AnalysisQing Huang, Sujana Borra, Jieni Li, et al.
Pain|September 1, 1991
Epidural opiates and local anesthetics for the management of cancer painQuinn Hogan, David J Haddox, Stephen Abram, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2006
Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14Andre Konski, Michelle Desilvio, William Hartsell, et al.
Future Oncology (London, England)|August 30, 2023
Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?Stephen J Freedland, Krishnan Ramaswamy, Ahong Huang, et al.
Frontiers in Medicine|July 24, 2023
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigationsPatrick Silva, Nora Janjan, Kenneth S Ramos, et al.
Future Oncology (London, England)|October 13, 2022
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?Daniel J George, Krishnan Ramaswamy, Ahong Huang, et al.
American Journal of Clinical Oncology|June 24, 2009
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastasesAndre Konski, Jennifer James, William Hartsell, et al.
Cancer|February 25, 2003
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic indexArthur Hung, Christopher Crane, Marc Delclos, et al.
Pageof 4